Sodium-Glucose Cotransporter 2 Inhibitors Preceding ST-Segment Elevation Myocardial Infarction: Global Proteomics and Pathobiological Insights
{{output}}
Background: While sodium-glucose cotransport 2 receptor inhibitors (SGLT2i) improve post infarction cardiovascular outcomes, limited understanding exists on how these agents influence pathophysiology preceding myocardial infarcti... ...
